58 results
8-K
EX-10.1
ITCI
Intra-Cellular Therapies Inc
18 Jun 24
Departure of Directors or Certain Officers
4:16pm
goals or other criteria. The vesting terms of individual Options or SARs may vary. The provisions of this Section 5(f) are subject to Section 2(f
8-K
EX-99.1
ITCI
Intra-Cellular Therapies Inc
18 Jun 24
Other Events
7:37am
an unmet need; the goals of our development programs; our beliefs about the potential utility of our product candidates; and development efforts and plans
8-K
EX-99.1
ITCI
Intra-Cellular Therapies Inc
7 May 24
Intra-cellular Therapies Reports First Quarter 2024 Financial Results
7:40am
will be predictive of future real-world results; whether CAPLYTA will serve an unmet need; the goals of our development programs; our beliefs about
8-K
ITCI
Intra-Cellular Therapies Inc
16 Apr 24
Lumateperone 42 mg achieved statistically significant and clinically meaningful results in both the primary and the key secondary endpoints
7:10am
; whether CAPLYTA will serve an unmet need; the goals of the Company’s development programs; and the Company’s beliefs about the potential utility of its
8-K
EX-99.1
vkpy35klq1a5wedos
16 Apr 24
Lumateperone 42 mg achieved statistically significant and clinically meaningful results in both the primary and the key secondary endpoints
7:10am
8-K
EX-99.1
p5aq72va4rvhk1bd
22 Feb 24
Intra-cellular Therapies Reports Fourth Quarter and Full-year 2023 Financial Results and Provides Corporate Update
7:39am
8-K
EX-99.1
91kt7np fb
2 Nov 23
Intra-cellular Therapies Reports Third Quarter 2023 Financial Results and Raises 2023 Caplyta Sales Guidance
8:01am
8-K
EX-99.1
w3vrg6k3
3 Aug 23
Intra-cellular Therapies Reports Second Quarter 2023 Financial Results and Raises 2023 Caplyta Sales Guidance
7:39am
8-K
EX-99.1
x7ozhk89tv
4 May 23
Intra-cellular Therapies Reports First Quarter 2023 Financial Results and Provides Corporate Update
7:37am
8-K
EX-99.1
g0aa3un1cfzpibgfbl6
3 Nov 22
Intra-cellular Therapies Reports Third Quarter 2022 Financial Results and Provides Corporate Update
7:35am
424B5
sbtzijd
5 Jan 22
Prospectus supplement for primary offering
4:51pm
424B5
al45h4
3 Jan 22
Prospectus supplement for primary offering
5:30pm